Circulating tumor cells

Highlight on practical implications

Paola Gazzaniga, Cristina Raimondi, Angela Gradilone, Giuseppe Naso, Enrico Cortesi, Luigi Frati

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch® system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate cancer; in these cancer types, a rise in the CTC count at any time during treatment predicts a poor outcome. Nevertheless, the clinical utility of monitoring CTC counts remains controversial, and what to do when CTC counts rise during therapy still remains an unanswered question. In this report, we suggest how to integrate CTC counts with their molecular characterization to better translate biologic information obtained on CTCs into daily clinical practice.

Original languageEnglish
Pages (from-to)7-11
Number of pages5
JournalMolecular Diagnosis and Therapy
Volume16
Issue number1
DOIs
Publication statusPublished - 2012

Fingerprint

Circulating Neoplastic Cells
Cell Count
Colorectal Neoplasms
Neoplasms
Prostatic Neoplasms
Epithelial Cells
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Medicine(all)
  • Pharmacology

Cite this

Gazzaniga, P., Raimondi, C., Gradilone, A., Naso, G., Cortesi, E., & Frati, L. (2012). Circulating tumor cells: Highlight on practical implications. Molecular Diagnosis and Therapy, 16(1), 7-11. https://doi.org/10.2165/11594520

Circulating tumor cells : Highlight on practical implications. / Gazzaniga, Paola; Raimondi, Cristina; Gradilone, Angela; Naso, Giuseppe; Cortesi, Enrico; Frati, Luigi.

In: Molecular Diagnosis and Therapy, Vol. 16, No. 1, 2012, p. 7-11.

Research output: Contribution to journalArticle

Gazzaniga, P, Raimondi, C, Gradilone, A, Naso, G, Cortesi, E & Frati, L 2012, 'Circulating tumor cells: Highlight on practical implications', Molecular Diagnosis and Therapy, vol. 16, no. 1, pp. 7-11. https://doi.org/10.2165/11594520
Gazzaniga, Paola ; Raimondi, Cristina ; Gradilone, Angela ; Naso, Giuseppe ; Cortesi, Enrico ; Frati, Luigi. / Circulating tumor cells : Highlight on practical implications. In: Molecular Diagnosis and Therapy. 2012 ; Vol. 16, No. 1. pp. 7-11.
@article{2a1a5c79da36431f88aa4768eb7f53dc,
title = "Circulating tumor cells: Highlight on practical implications",
abstract = "Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch{\circledR} system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate cancer; in these cancer types, a rise in the CTC count at any time during treatment predicts a poor outcome. Nevertheless, the clinical utility of monitoring CTC counts remains controversial, and what to do when CTC counts rise during therapy still remains an unanswered question. In this report, we suggest how to integrate CTC counts with their molecular characterization to better translate biologic information obtained on CTCs into daily clinical practice.",
author = "Paola Gazzaniga and Cristina Raimondi and Angela Gradilone and Giuseppe Naso and Enrico Cortesi and Luigi Frati",
year = "2012",
doi = "10.2165/11594520",
language = "English",
volume = "16",
pages = "7--11",
journal = "Molecular Diagnosis and Therapy",
issn = "1177-1062",
publisher = "Adis International Ltd",
number = "1",

}

TY - JOUR

T1 - Circulating tumor cells

T2 - Highlight on practical implications

AU - Gazzaniga, Paola

AU - Raimondi, Cristina

AU - Gradilone, Angela

AU - Naso, Giuseppe

AU - Cortesi, Enrico

AU - Frati, Luigi

PY - 2012

Y1 - 2012

N2 - Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch® system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate cancer; in these cancer types, a rise in the CTC count at any time during treatment predicts a poor outcome. Nevertheless, the clinical utility of monitoring CTC counts remains controversial, and what to do when CTC counts rise during therapy still remains an unanswered question. In this report, we suggest how to integrate CTC counts with their molecular characterization to better translate biologic information obtained on CTCs into daily clinical practice.

AB - Circulating tumor cells (CTCs) are cells of presumed epithelial origin, whose prognostic and predictive value in metastatic cancer patients has recently been demonstrated. To date, the count of CTCs through the CellSearch® system represents a valid approach for monitoring disease status in patients with metastatic colorectal, breast, and prostate cancer; in these cancer types, a rise in the CTC count at any time during treatment predicts a poor outcome. Nevertheless, the clinical utility of monitoring CTC counts remains controversial, and what to do when CTC counts rise during therapy still remains an unanswered question. In this report, we suggest how to integrate CTC counts with their molecular characterization to better translate biologic information obtained on CTCs into daily clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84857532379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857532379&partnerID=8YFLogxK

U2 - 10.2165/11594520

DO - 10.2165/11594520

M3 - Article

VL - 16

SP - 7

EP - 11

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

IS - 1

ER -